<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

CP 316819

產(chǎn)品貨號

Axon 1847 CAS [186392-43-8] MF C21H22ClN3O4MW 415.87 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Potent glycogen phosphorylase (GPase) inhibitor (IC50: 40 nM against human liver GPα). CP-316819 facilitates glycogen utilization in the brain, prevents neuronal cell death and maintains brain electrical currents References Certificates Categories Extra info SW Suh et al. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(...). J. Pharmacol. Exp. Ther. 2007, 1, 45-50.? ? DG Baker et al. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 2005, 54, 2453.? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism GPase EC 2.4.1.1 Glycogen Phosphorylase (GPase) inhibitor Chemical name 5-chloro-N-((2S,3R)-3-hydroxy-4-(methoxy(methyl)amino)-4-oxo-1-phenylbutan-2-yl)-1H-indole-2-carboxamide Parent CAS No. [186392-43-8] Order Size Unit Price Stock 10 mg €135.00 In Stock

產(chǎn)品價格

現(xiàn)貨詢價，電話：010-67529703

產(chǎn)品規(guī)格

產(chǎn)品品牌

axonmedchem

產(chǎn)品概述

產(chǎn)品詳情

CP 316819

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1847

CAS [186392-43-8]

MF C21H22ClN3O4
MW 415.87

Purity: 99%
Optical purity: Optically pure
Soluble in DMSO

CP 316819

Description

Potent glycogen phosphorylase (GPase) inhibitor (IC50: 40 nM against human liver GPα). CP-316819 facilitates glycogen utilization in the brain, prevents neuronal cell death and maintains brain electrical currents

SW Suh et al. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(...). J. Pharmacol. Exp. Ther. 2007, 1, 45-50.?

DG Baker et al. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 2005, 54, 2453.?

Certificate of Analysis
Material Safety Data Sheet

Cell Signaling & Oncology Diabetes & Metabolism GPase EC 2.4.1.1

Glycogen Phosphorylase (GPase) inhibitor

Chemical name

5-chloro-N-((2S,3R)-3-hydroxy-4-(methoxy(methyl)amino)-4-oxo-1-phenylbutan-2-yl)-1H-indole-2-carboxamide

Parent CAS No.

[186392-43-8]

產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>